COTY
Get informed when a big investor buys or sells
+ FollowMay 9, 2023 - AI Summary
Undervalued by 220.4% based on the discounted cash flow analysis.
| Market cap | $1.88 Billion |
|---|---|
| Enterprise Value | $5.26 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.44 |
| Beta | 1.06 |
| Outstanding Shares | 879,900,000 |
| P/E Ratio | -3.52 |
|---|---|
| PEG | -594.85 |
| Price to Sales | 0.32 |
| Price to Book Ratio | 0.63 |
| Enterprise Value to Revenue | 0.91 |
| Enterprise Value to EBIT | 18.34 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.69 |
| Debt to Equity | 1.18 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 3.4279▲ 222.02% |
|---|---|
| Total Calls | 210,800▼ 40.27% |
| Total Puts | 722,600▲ 69.54% |
Holdings and activity of institutional investors.
| Ownership % | 37.85%▲ 0.37% |
|---|---|
| Total Invested | $667.70M▼ 34.04% |
| Investors Holding | 328▲ 20.00% |
No data
Provides critical analysis and 'revenue estimates' for tax legislation, directly influencing the tax policies that profoundly impact Coty's corporate structure and profitability.
Directly controls tax policy (corporate tax rates, credits) and trade policy (tariffs, international agreements) which have a significant and direct impact on Coty's profitability and global operations.
Directly regulates the FDA, which oversees the safety and labeling of cosmetic and chemical products manufactured by Coty, and influences labor laws impacting manufacturing.
Directly regulates the EPA, which has significant oversight over chemical manufacturing processes, emissions, and product ingredient safety relevant to Coty's operations.